Design of new synthetic methodologies
- Design, synthesis and biological evaluation of new inhibitors of GPCR, TK and RTK (cancer), HIV (AIDS), HCV (Hepatitis C) and Myotonic Dystrophy.
- Design of new synthetic methodologies for heterocyclic systems based on microwaves.
MEMBER OF:
School of Engineering
Pharmaceutical Chemistry Group
The research focuses on two main areas: New Drugs in Biomedicine and Health Sciences and Flow Chemistry Processes.
LATEST PROJECTS
DisX4lymph (Interrupción de la interacción estroma-tumor en linfoma B utilizando inhibidores CXCR4 y degradadores IRAK4)
Diseño y síntesis de inhibidores alostéricos de CXCR4 y degradadores de IRAK4 como potencial tratamiento de linfoma de células B.
Funding Agency:
Research Group Link:
Pharmaceutical Chemistry Group (GQF)
PANCTKI (Nuevos inhibidores multidiana en terapia del cancer de pancreas)
Inhibidores de Tirosina Quinasas Duales en Cáncer de Páncreas: Cribado Virtual, Síntesis, Evaluación Biológica in vitro (2D y 3D) e in vivo.
Funding Agency:
Research Group Link:
Pharmaceutical Chemistry Group (GQF)
ProteoBlood (Red cooperativa franco-española para el análisis de proteinopatías y el desarrollo de terapias individualizadas en cánceres hematológicos)
Estudio de la homeostasis proteica en los dos subtipos de leucemia y linfoma.
Funding Agency:
Research Group Link:
Pharmaceutical Chemistry Group (GQF)